Zydus receives USFDA final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets | Tech Reddy

Zydus receives USFDA final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets

 | Tech Reddy

[ad_1] Zydus Lifesciences has received approval from the United States Food and Drug Administration (USFDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg (USRLD : Ziac tablets) received final marketing approval. The combination of bisoprolol fumarate and hydrochlorothiazide is indicated for the treatment of high blood pressure … Read more

Lupine Receives USFDA Presumptive Approval for ANDA Drospirenone Tablets | Tech Reddy

Lupine Receives USFDA Presumptive Approval for ANDA Drospirenone Tablets

 | Tech Reddy

[ad_1] Business standard Lupine today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Drospirenone Tablets, 4 mg, to market the generic equivalent of Exeltis, Slind Tablets, 4 … Read more

Glenmark Pharma receives USFDA approval for sodium phenylbutyrate tablets | Tech Reddy

Glenmark Pharma receives USFDA approval for sodium phenylbutyrate tablets

 | Tech Reddy

[ad_1] Glenmark Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (US FDA) for Sodium Phenylbutyrate Tablets USP, 500 mg, Generic Version Buphenyl Tablets, 500 mg, Horizon Therapeutics, LLC. According to the filings, Glenmark’s Sodium Phenylbutyrate Tablets USP, 500 mg, is distributed in the USA by Glenmark Pharmaceuticals Inc., USA. … Read more